Nomura Asset Management CO LTD Eli Lilly & CO Transaction History

Nomura Asset Management CO LTD

$28.9 Billion
Q2 2024

A detailed history of Nomura Asset Management CO LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 332,313 shares of LLY stock, worth $292 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares

332,313

Previous 387,849 14.32%

Holding current value

$292 Million

Previous $302 Million 0.29%

% of portfolio

1.04%

Previous 1.11%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $40.3 Million - $50.5 Million	-55,536 Reduced 14.32%	332,313 $301 Million
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $4.54 Million - $6.07 Million	7,666 Added 2.02%	387,849 $302 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $11.4 Million - $13.5 Million	21,755 Added 6.07%	380,183 $222 Million
Q3 2023 Nov 03, 2023	SELL	$434.7 - $599.3 $19.2 Million - $26.5 Million	-44,138 Reduced 10.96%	358,428 $193 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $5.6 Million - $7.49 Million	15,966 Added 4.13%	402,566 $189 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $15.7 Million - $18.4 Million	50,439 Added 15.0%	386,600 $133 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $13.2 Million - $15.3 Million	40,902 Added 13.85%	336,161 $123 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $12.4 Million - $14.1 Million	-41,804 Reduced 12.4%	295,259 $95.5 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $7.29 Million - $8.56 Million	26,149 Added 8.41%	337,063 $109 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $14.9 Million - $18.5 Million	-63,519 Reduced 16.96%	310,914 $89 Million
Q4 2021 Feb 01, 2022	BUY	$224.85 - $279.04 $22.3 Million - $27.7 Million	99,393 Added 36.14%	374,433 $103 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $333,508 - $410,428	1,505 Added 0.55%	275,040 $63.5 Million
Q2 2021 Aug 06, 2021	BUY	$180.55 - $233.54 $2.13 Million - $2.75 Million	11,791 Added 4.5%	273,535 $62.8 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $815,684 - $1.06 Million	-4,964 Reduced 1.86%	261,744 $48.9 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $1.86 Million - $2.46 Million	14,251 Added 5.64%	266,708 $45 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $9.29 Million - $10.7 Million	63,503 Added 33.61%	252,457 $37.4 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $1.55 Million - $1.86 Million	-11,344 Reduced 5.66%	188,954 $31 Million
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $588,464 - $728,351	4,943 Added 2.53%	200,298 $27.8 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $2.3 Million - $2.85 Million	-21,526 Reduced 9.93%	195,355 $25.7 Million
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $2 Million - $2.18 Million	18,773 Added 9.48%	216,881 $24.3 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $424,214 - $495,166	-3,829 Reduced 1.9%	198,108 $21.9 Million
Q1 2019 May 10, 2019	SELL	$111.31 - $131.02 $33.9 Million - $39.9 Million	-304,807 Reduced 60.15%	201,937 $26.2 Million
Q4 2018 Feb 12, 2019	BUY	$105.9 - $118.64 $2.35 Million - $2.63 Million	22,169 Added 4.57%	506,744 $58.6 Million
Q3 2018 Nov 07, 2018	SELL	$85.86 - $107.31 $22.3 Million - $27.9 Million	-259,951 Reduced 34.91%	484,575 $52 Million
Q2 2018 Aug 03, 2018	SELL	$75.7 - $86.88 $1.92 Million - $2.2 Million	-25,300 Reduced 3.29%	744,526 $63.5 Million
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $724,734 - $855,501	9,766 Added 1.28%	769,826 $59.6 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $12.2 Million - $13.1 Million	148,955 Added 24.37%	760,060 $64.2 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $4.47 Million - $4.96 Million	58,011 Added 10.49%	611,105 $52.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	553,094	553,094 $45.5 Million

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Account

Nomura Asset Management CO LTD Eli Lilly & CO Transaction History